About erGenetics
Under the direction of Dr. Aurelia Meloni-Ehrig, an award-winning cytogeneticist, and Dr. Zunyan Dai (Dr. Day), dual-boarded in both cytogenetics and molecular genetics, erGenetics is a team with a combined over 55 years of experience in cytogenetics and molecular genetics in both research and clinical settings. It provides cytogenetics and molecular director coverage, consultation, and education and training for laboratory personnel. erGenetics provides a wide range of specialized consulting services for cytogenetic and molecular laboratories within academic institutions, hospitals, and commercial organizations.
Having held leadership positions in both academia and high-volume commercial laboratories, and contributed to the training of post-doctoral fellows and pathology residents throughout the country, Dr. Meloni-Ehrig and Dr. Zunyan Dai (Dr. Day) are uniquely qualified to professional cytogenetics consulting services, including:
- Case sign out and consulting including - cytogenetics, FISH, and microarray for cancer, prenatal, and postnatal cases, molecular non-sequencing assays, Sanger oncology.
- Computer-assisted case report sign out for overflow cases
- Report generation (provide diagnostic and prognostic significance of genetics aberrations useful for patient management, follow up, treatment of choice, etc.)
- Dr. Meloni-Ehrig also serves as a cytogenetic reviewer for the Cancer and Leukemia Group B (CALGB), has director approval by the Children's Oncology Group (COG), and is licensed in New York (cytogenetics and molecular oncology) and Florida (cytogenetics).
Meet Aurelia Meloni-Ehrig, PhD, DSc, ABMGG, FACMG
Founder, erGenetics
Dr. Aurelia Meloni-Ehrig is board certified in clinical cytogenetics by the American Board of Medical Genetics and Genomics (ABMGG) and a fellow of the American College of Medical Genetics (FACMG).
Prior to discovering her interest in and passion for cytogenetics, Dr. Meloni-Ehrig earned her doctor of science (DSc) with a specialization in marine biology from the University of Studies in Cagliari, Sardinia, Italy. Through a twist of fate, she began a two-year fellowship training program in cytogenetics in Sardinia in 1983. After that, she applied for and obtained a two-year research grant that brought her to the Genetic Center in Scottsdale, Arizona.
In 1986, Dr. Meloni-Ehrig began training in cancer cytogenetics at Southwest Biomedical Research Institute in Scottsdale, Arizona, under the leadership of Dr. Avery A. Sandberg, one of the pioneers in cancer cytogenetics.
During this time, Dr. Meloni-Ehrig obtained her doctor of philosophy (PhD) in microbiology at Arizona State University in Tempe, Arizona. She completed her post-graduate fellowship training in clinical cytogenetics in the department of pediatrics at the University of Utah in Salt Lake City, Utah, where she was also appointed assistant professor in the oncological sciences department at the Huntsman Cancer Institute.
A two-time recipient of the Cancer Cytogeneticist of the Year Award by Quest Diagnostics’ prestigious Nichols Institute, Dr. Meloni-Ehrig has been awarded grants by the Veterans Administration, the National Cancer Institute, and Primary Children’s Medical Center Foundation.
The author or coauthor of over 100 peer-reviewed articles and book chapters, Dr. Meloni-Ehrig serves as section editor of tumor genetics for the open access online journal Molecular Cytogenetics, which offers immediate access to anyone wishing to view their articles.
Dr. Meloni-Ehrig also serves as a cytogenetic reviewer for the Cancer and Leukemia Group B (CALGB), has director approval by the Children's Oncology Group (COG), and is licensed in New York (cytogenetics and molecular oncology), California, and Florida (cytogenetics).
Dr. Meloni-Ehrig is certified as a Laboratory Director by CLIA (ID number 11D2129437).
View Dr. Meloni-Ehrig’s CV, including her complete bibliography.
Read Dr. Meloni-Ehrig’s interview in the Journal of the Association of Genetic Technologists.
At erGenetics, your success is our business. We look forward to speaking with you and appreciate the opportunity to partner with your organization. To inquire about our consulting services, please call our office at 540 878-8276 or contact us online.
Meet Zunyan Dai (Dr. Day), PhD, DABMGG
Co-Founder, erGenetics
Dr. Day is board-certified in clinical cytogenetics and clinical molecular genetics by the American Board of Medical Genetics and Genomics (ABMGG).
He has a New York Certificate of Qualification as a laboratory director for clinical cytogenetics, molecular genetics, and molecular oncology.
Dr. Day received his B.S. in Medical Technology and M.S. degree in Oncology from Shanghai Medical University, his Ph.D. degree in Human Cancer Genetics, and his postdoctoral training in Pharmacogenomics from The Ohio State University Medical Center. He completed his fellowship training in clinical cytogenetics and molecular genetics in the Department of Pediatrics (Nationwide Children’s Hospital) and the Department of Pathology at The Ohio State University.
Dr. Day served as a Technical Director of cytogenetics, molecular genetics, and molecular oncology at Quest Diagnostics Nichols Institute, Chantilly VA.
Zunyan Dai also served as an Assistant Professor of Human Genetics at Emory University, and Senior Director of the Cytogenetics Laboratory, and Director of the Molecular Laboratory at Emory Genetics Laboratory.
He has more than 40 published papers in internationally acclaimed journals. Dr. Day has been involved in teaching clinical molecular genetics and cytogenetics fellows, genetic counseling students, and medical students. Dr. Day’s major service efforts involve clinical laboratory diagnosis of molecular and chromosomal disorders, using chromosome analysis, microarray, FISH, sequencing, and related techniques.
Dr. Dai is certified as a Laboratory Director by CLIA (ID number 11D2197431).
View Dr. Zunyan's CV, including his complete bibliography.
